drugset / Trial / NCT03394677
Study of RVT-501 Topical Ointment in Pediatric Patients With Atopic Dermatitis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a multi-center, randomized, vehicle controlled, double-blind Phase 2 study in pediatric patients age 2-17 years old with mild to moderate atopic dermatitis.
Timeline
- Start
- 2018-01-25
- Primary completion
- 2018-07-02
- Completion
- 2018-07-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LOTAMILAST | Small molecule | 0.5 % | Topical |